Support

BioXFEL member Belinda Pastrana will be giving a talk at the BIOProcessing Summit in Boston, MA. Her talk "Novel Approach towards the Evaluation of Critical Quality Attributes and Stability of Proteins" centers on therapeutic proteins. Therapeutic proteins are highly complex molecules; their CQAs require diverse bioanalytical techniques to comply with reporting requirements to regulatory agencies. Ideally a multivariate analysis would also be needed to address stability, yet even under the current state of technology, including proteomic and high resolution, techniques can be costly and time consuming. Belinda and her team have developed a DOE, label free method using Best-in-Class platform technology to aid in addressing this concern.

The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today's bioprocess challenges. Now in its ninth year, the event has grown to include 18 distinct conferences with weeklong programming on upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing. Along with the impressive array of conferences, the Summit also includes short courses and training seminars that provide in-depth coverage of critical bioprocess topics.

Topics Covered

• Biologics Formulation and Stability
• Management of DP temperature excursions during shipping and in clinic
• Use of a platform formulation versus innovative formulation approaches for accelerated development
• New Tools for Characterization of Protein Aggregation and Stability

Dates:  August 21-22, 2017

Location: Westin Copley Place, Boston, MA

Registration: 

Advance Registration Deadline until July 28, 2017 All registration after this date will be at increased cost.

For registration and more information